Simon Holliday1,2, Simon Morgan3, Amanda Tapley3, Adrian Dunlop1,2, Kim Henderson3, Mieke van Driel4, Neil Spike5,6, Lawrie McArthur7, Jean Ball8, Chris Oldmeadow9, Parker Magin1,3. 1. School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia. 2. Drug and Alcohol Clinical Services, Hunter New England Local Health District, NSW, Australia. 3. General Practice Training Valley to Coast, Mayfield, NSW, Australia. 4. Discipline of General Practice, School of Medicine, The University of Queensland, Brisbane, Queensland, Australia. 5. Department of General Practice, The University of Melbourne, Victoria, Australia. 6. Director of Medical Education and Training, VMA General Practice Training, Melbourne, Victoria, Australia. 7. Director of Medical Education and Training, Adelaide to Outback GP Training, Adelaide, South Australia. 8. Clinical Research Design, Information Technology and Statistical Support (CReDITSS), Hunter Medical Research Institute, Newcastle, NSW, Australia. 9. Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Newcastle, NSW, Australia.
Abstract
OBJECTIVE: With escalating opioid prescribing come individual and public health harms. To inform quality improvement measures, understanding of opioid prescribing is essential. We aimed to establish consultation-level prevalence and associations of opioid prescribing. DESIGN: A cross-sectional secondary analysis from a longitudinal multisite cohort study of general practitioner (GP) vocational trainees: "Registrar Clinical Encounters in Training." SETTING: Four of Australia's seventeen GP Regional Training Providers, during 2010-13. SUBJECTS: GP trainees. METHODS: Practice and trainee demographic data were collected as well as patient, clinical and educational data of 60 consecutive consultations of each trainee, each training term. Outcome factors were any opioid analgesic prescription and initial opioid analgesic prescription for a specific problem for the first time. RESULTS: Overall, 645 trainees participated. Opioids comprised 4.3% prescriptions provided for 3.8% of patients. Most frequently prescribed were codeine (39.9%) and oxycodone (33.4%). Prescribing was for acute pain (29.3%), palliative care (2.6%) or other indications (68.1%). Most prescribing involved repeat prescriptions for pre-existing problems (62.7% of total). Other associations included older patients; prescriber and patient male gender; Aboriginal/Torres Strait Islander status; rural and disadvantaged locations; longer consultations; and generation of referrals, follow-up, and imaging requests. Opioid initiation was more likely for new patients with new problems, but otherwise associations were similar. Trainees rarely reported addiction risk-mitigation strategies. CONCLUSIONS: Most opioids were prescribed as maintenance therapy for non-cancer pain. Demographic associations with opioid analgesic prescribing resemble those presenting for opioid dependency treatment. Our findings should inform measures by regulators and medical educators supporting multimodal pain management.
OBJECTIVE: With escalating opioid prescribing come individual and public health harms. To inform quality improvement measures, understanding of opioid prescribing is essential. We aimed to establish consultation-level prevalence and associations of opioid prescribing. DESIGN: A cross-sectional secondary analysis from a longitudinal multisite cohort study of general practitioner (GP) vocational trainees: "Registrar Clinical Encounters in Training." SETTING: Four of Australia's seventeen GP Regional Training Providers, during 2010-13. SUBJECTS: GP trainees. METHODS: Practice and trainee demographic data were collected as well as patient, clinical and educational data of 60 consecutive consultations of each trainee, each training term. Outcome factors were any opioid analgesic prescription and initial opioid analgesic prescription for a specific problem for the first time. RESULTS: Overall, 645 trainees participated. Opioids comprised 4.3% prescriptions provided for 3.8% of patients. Most frequently prescribed were codeine (39.9%) and oxycodone (33.4%). Prescribing was for acute pain (29.3%), palliative care (2.6%) or other indications (68.1%). Most prescribing involved repeat prescriptions for pre-existing problems (62.7% of total). Other associations included older patients; prescriber and patient male gender; Aboriginal/Torres Strait Islander status; rural and disadvantaged locations; longer consultations; and generation of referrals, follow-up, and imaging requests. Opioid initiation was more likely for new patients with new problems, but otherwise associations were similar. Trainees rarely reported addiction risk-mitigation strategies. CONCLUSIONS: Most opioids were prescribed as maintenance therapy for non-cancer pain. Demographic associations with opioid analgesic prescribing resemble those presenting for opioid dependency treatment. Our findings should inform measures by regulators and medical educators supporting multimodal pain management.
Authors: Francisca N Wagemaakers; Samantha A Hollingworth; Sanne Kreijkamp-Kaspers; Ernest H L Tee; Anne J Leendertse; Mieke L van Driel Journal: Int J Clin Pharm Date: 2017-06-12
Authors: Parker Magin; Anna Ralston; Amanda Tapley; Elizabeth Holliday; Jean Ball; Mieke L van Driel; Andrew Davey; Linda Klein; Kristen FitzGerald; Neil Spike; Alison Fielding Journal: BMJ Open Date: 2022-05-11 Impact factor: 3.006